A recent study has shown that mutation in PIK3CA corresponds to a poor prognosis in patients with hormone receptor-positive metastatic breast cancer but a good prognosis in patients with triple-negative breast cancer [56]. Here, NR4A1 is linked to triple-negative breast carcinoma.